Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
41,966,083
-
Total 13F shares
-
9,581,087
-
Share change
-
+3,970,764
-
Total reported value
-
$84,025,633
-
Put/Call ratio
-
5.2%
-
Price per share
-
$8.77
-
Number of holders
-
52
-
Value change
-
+$38,213,873
-
Number of buys
-
38
-
Number of sells
-
13
Institutional Holders of Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM) as of Q2 2023
As of 30 Jun 2023,
Carisma Therapeutics Inc. - Common Stock, $0.001 par value per share (CARM) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,581,087 shares.
The largest 10 holders included
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, BlackRock Inc., TPG GP A, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, and Nuveen Asset Management, LLC.
This page lists
52
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.